Top Qs
Timeline
Chat
Perspective

2,5-Dimethoxy-4-isobutylamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

2,5-Dimethoxy-4-isobutylamphetamine
Remove ads

2,5-Dimethoxy-4-isobutylamphetamine (DOIB or DOiBu) is a serotonin 5-HT2A receptor agonist, serotonergic psychedelic, and anti-inflammatory drug of the phenethylamine, amphetamine, and DOx families.[1][2][3][4][5] It is part of the series of straight-chain and branched-chain 4-alkylated DOx drugs that also includes DOM, DOET, DOPR, DOBU, DOAM, and DOHx, among others.[4]

Quick Facts Clinical data, Other names ...

The drug is a full agonist of the serotonin 5-HT2A receptor, with an EC50Tooltip half-maximal effective concentration of 12.6 nM and an EmaxTooltip maximal efficacy of 98.8%, both for calcium mobilization.[5] It is about one-third as potent as DOM in rodent drug discrimination tests and also substitutes for LSD in these tests.[3][6][1][2] In humans, DOIB is active at doses of 10 to 15 mg orally, and hence is also about one-third as potent as DOM in humans as in rodents.[2][3][7][8][9]

In addition to its psychedelic effects, DOIB has highly potent anti-inflammatory effects in preclinical research.[5] It was more potent than almost any other tested psychedelic.[5] The drug was notably more potent than (R)-DOI, but was less potent than 2C-I (the most potent assessed compound).[5]

Some other notable analogues of DOIB include DOBU (n-butyl), DOSB (sec-butyl), and DOTB (tert-butyl).[1][2][7][8][9]

Thumb
DOIB, DOSB, and DOTB.[1][2][7][8][9]
Remove ads

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads